StockData

Aterian vs Natural Health Trends

ATER and NHTC side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ATER and NHTC compare

Aterian is the larger company, worth 2.5 times as much as Natural Health Trends ($15.8M against $6.3M).

Natural Health Trends grew revenue faster over the last twelve months (−16.5% versus −33.0% for Aterian).

Natural Health Trends keeps more of each dollar of sales as profit, with a net margin of −4.2% compared with −49.3% at Aterian.

Natural Health Trends pays a dividend yielding 53.7%; Aterian does not pay one.

Natural Health Trends scores higher on the StockData Score (12 against 5 for Aterian), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricATERNHTC
Size and price
Market cap$15.8M$6.3M
Share price$0.879$0.746
Change, 1 year2.9%−79.3%
Change, 5 years−98.7%−89.6%
Beta (5Y)1.520.73
Employees74120
StockData Score
Total score512 (better)
Valuation score33
Growth score01 (better)
Performance score1 (better)0
Health score15 (better)
Dividend score03 (better)
Valuation
P/S0.5×0.2× (better)
P/B1.3×0.4× (better)
FCF yield−16.4% (better)−73.7%
Fair value$2.11$2.95
Margin of safety58.3%74.7% (better)
Growth
Revenue growth (TTM)−33.0%−16.5% (better)
Revenue growth, 5Y average−18.0%−8.5% (better)
Profitability
Gross margin56.1%74.3% (better)
Operating margin−49.6%−5.9% (better)
Net margin−49.3%−4.2% (better)
FCF margin−7.6% (better)−13.7%
Return on equity−91.3%−6.9% (better)
Return on invested capital−112%–
Financial health
Debt / equity–0.00
Interest coverage−16.4×–
Current ratio2.13 (better)2.13
Altman Z-score−43.30−0.17 (better)
Piotroski F-score33
Dividends and buybacks
Dividend yield–53.7%
Years of dividend growth–0
Dividend growth, 5Y average–0.00%
Shareholder yield0.00%53.7% (better)
Ownership
Held by institutions3.8%12.2%
Held by insiders–13.0%
Short interest, % of float–0.61%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.